ISSN: XXXX-XXXX

Evaluating the Cytotoxicity of 6-Mercaptopurine and Its Derivatives on Cancer Cells

Abstract

This research aims to find the cytotoxic effects of 6-Mercaptopurine (6-MP) and its derivatives, namely 6-Hydroxy-2-Mercaptopurine (6H2MP) and 2-Amino-9-butyl-6-Mercaptopurine (2A9B6-MP), on HepG2 and MCF-7 cancer cell lines. It utilizes quantitative methods to research cell viability via MTT assays at different concentrations of these compounds. The outcome showed that 6-MP has strong cytotoxicity on HepG2 cells, with MCF-7 being more resistant. Comparison studies suggested that 6-MP was more potent than its derivatives. The results have underlined the potential use of 6-MP in the treatment of liver cancer and point to a need for further research in molecular mechanisms and in vivo validations.

References

  1. Elion, G. B., & Hitchings, G. H. (1963). "The Biochemistry and Pharmacology of 6-Mercaptopurine and Azathioprine." Annals of the New York Academy of Sciences, 99(1), 10–19.
  2. Schwab, M., et al. (2008). "Pharmacogenomics of 6-mercaptopurine in childhood acute lymphoblastic leukemia." Current Opinion in Pediatrics, 20(6), 703–710.
  3. Lu, J., et al. (2020). "6-Mercaptopurine Derivatives in Cancer Therapy: Mechanistic Insights and Development Perspectives." Bioorganic & Medicinal Chemistry Letters, 30(16), 127415.
  4. Kumar N (2024) “Health Care DNS Tunnelling Detection Method via Spiking Neural Network” Lecture Notes in Electrical Engineering, Springer Nature, pp715-725. DOI: 10.1007/978-981-99-8646-0_56
  5. 2) N. Kumar, U S Rana and J. Baloni: “A Mathematical Model of Growth of Homogeneous Tumor with Delay Time” In International Journal of Engineering, vol-22(1), April -2009, pp. 49-56.( http://www.ije.ir/article_71759.html)
  6. Wang, L., et al. (2015). "Exploring the Cytotoxic Potential of 6-Mercaptopurine on Hepatocellular Carcinoma Cells." Cancer Chemotherapy and Pharmacology, 76(4), 785–796.
  7. Ali, S. M., & Ali, A. A. (2019). "Comparative Cytotoxicity Analysis of Purine Derivatives in HepG2 and MCF-7 Cell Lines." Journal of Cancer Research and Therapeutics, 15(6), 1203–1209.
  8. Zhang, J., et al. (2018). "Mechanisms of Cellular Resistance to 6-Mercaptopurine in Breast Cancer Cell Lines." Experimental and Therapeutic Medicine, 16(4), 2931–2940.
Download PDF

How to Cite

Pramod Kumar Arya, (2025-01-07 18:17:43.109). Evaluating the Cytotoxicity of 6-Mercaptopurine and Its Derivatives on Cancer Cells. Abhi International Journal of Biological Science, Volume shei9IKj93kNVodFcGtA, Issue 1.